跳至主要内容
临床试验/NCT04219566
NCT04219566已完成不适用

Pilot Study to Demonstration of Safety and Efficacy of VeSTAL Sleep Device in Human Subjects: Randomized Study of VeSTAL Compared to Sham Control as a Means of Improving Sleep as Determined by ISI Scores

Neurovalens Ltd.2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
2
主要终点
Change in Insomnia Severity Index (ISI) Scores

研究概览

简要总结

A randomized, double blind sham controlled clinical trial to evaluate the efficacy of vestibular nerve stimulation (VeNS) compared to a sham control a as a means of improving sleep as measured by ISI scores and EEG recordings

The purpose of this investigation device study is to collect data that will be used to design appropriate pivotal studies that can be used for regulatory submissions, primarily in the United States of America (USA), but it may also be used to support submissions in other regions, including the European Union (EU).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Double Blind (Subject, Nursing staff, Co-coordinators, Outcomes Assessor and any other study staff who have contact with the subject)

入排标准

年龄范围
18 Years 至 24 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Both genders
  • Ages 18-24 years inclusive
  • Score above 14 in the insomnia severity index questionnaire
  • Willingness to participate in the study.

排除标准

  • Use sleep medication
  • Ear problems
  • Under any kind of treatment
  • Practicing sleep improving techniques
  • Any other significant health-related problems.

结局指标

主要结局

Change in Insomnia Severity Index (ISI) Scores

时间窗: Day 0, Day 7, Day 14, Day 21, Day 28

ISI scores will be measured during the study and will be compared to baseline readings taken prior to intervention. Insomnia Severity Index scores range from 0 to 28. Scores greater than 15 indicate clinical insomnia.

次要结局

  • WHO Quality of Life (WHOQOL) Assessment(Day 0, Day 7, Day 14, Day 21, Day 28)
  • EEG Assessment(Day 0, Day 28)
  • Depression Anxiety Stress Scales (DASS) Assessment(Day 0, Day 7, Day 14, Day 21, Day 28)

研究者

发起方
Neurovalens Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验